“Rapid and relatively inexpensive cancer therapy.”

Stanford University touts a cancer 'vaccine'

#Health

Fri, Feb 2nd, 2018 11:00 by capnasty NEWS

With the understanding that DNA contains a sort of built-in timer that causes mutations — and possibly tumors — it may be encouraging to know that initial trials for a cancer "vaccine" look promising.

“When we use these two agents together, we see the elimination of tumors all over the body,” said Ronald Levy, MD, professor of oncology. “This approach bypasses the need to identify tumor-specific immune targets and doesn’t require wholesale activation of the immune system or customization of a patient’s immune cells.”

One agent is currently already approved for use in humans; the other has been tested for human use in several unrelated clinical trials. A clinical trial was launched in January to test the effect of the treatment in patients with lymphoma.

  717

 

You may also be interested in:

Where the HIV Pandemic Originated From
Pessimism is Good for You
“We can make aged cells younger.”
Cure for cancer worth $50 trillion
"The first commercial gene therapy to provide an outright cure for a deadly disease."